In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Staar Surgical Co’s stock clocked out at $17.44, down -0.17% from its previous closing price of $17.47. In other words, the price has decreased by -$0.17 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
To gain a deeper understanding of STAA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.07 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 21, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $17.
Mizuho Downgraded its Outperform to Neutral on February 12, 2025, whereas the target price for the stock was revised from $45 to $17.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 08 ’25 when BROADWOOD PARTNERS, L.P. bought 178,127 shares for $15.32 per share. The transaction valued at 2,729,095 led to the insider holds 13,510,391 shares of the business.
BROADWOOD PARTNERS, L.P. bought 8,200 shares of STAA for $123,676 on Apr 09 ’25. The 10% Owner now owns 13,518,591 shares after completing the transaction at $15.08 per share. On Apr 10 ’25, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 900 shares for $15.18 each. As a result, the insider paid 13,658 and bolstered with 13,519,491 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.09 while its Price-to-Book (P/B) ratio in mrq is 2.47.
Stock Price History:
Over the past 52 weeks, STAA has reached a high of $49.86, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -2.06%, while the 200-Day Moving Average is calculated to be -26.40%.
Shares Statistics:
A total of 49.52M shares are outstanding, with a floating share count of 49.16M. Insiders hold about 0.74% of the company’s shares, while institutions hold 107.87% stake in the company.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate the current performance of Staar Surgical Co (STAA) in the stock market.The consensus estimate for the next quarter is $0.2, with high estimates of $0.35 and low estimates of $0.02.
Analysts are recommending an EPS of between -$0.54 and -$1.64 for the fiscal current year, implying an average EPS of -$1.14. EPS for the following year is $0.2, with 8.0 analysts recommending between $1.13 and -$0.67.
Revenue Estimates
In the current quarter, 12 analysts expect revenue to total $40.87M. It ranges from a high estimate of $45M to a low estimate of $39.2M. As of the current estimate, Staar Surgical Co’s year-ago sales were $99MFor the next quarter, 12 analysts are estimating revenue of $90.53M. There is a high estimate of $99.3M for the next quarter, whereas the lowest estimate is $83.04M.
A total of 13 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $272.8M, while the lowest revenue estimate was $242.1M, resulting in an average revenue estimate of $255.2M. In the same quarter a year ago, actual revenue was $313.9MBased on 14 analysts’ estimates, the company’s revenue will be $325.32M in the next fiscal year. The high estimate is $391.6M and the low estimate is $266.4M.
